Buy Mobic

Mobic

What is Mobic?

Mobic is a brand name for the prescription medication meloxicam, an oral non-steroidal anti-inflammatory drug (NSAID). It is available in tablet form at strengths of 7.5 mg and 15 mg. In the United Kingdom, Mobic is a prescription-only medicine (POM) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). Melatonin is the active ingredient, and it works by reducing inflammation and pain.

How Mobic Works in the Body

Meloxicam belongs to the NSAID class that selectively inhibits the cyclo-oxygenase-2 (COX-2) enzyme. COX-2 is involved in the production of prostaglandins-chemical messengers that promote inflammation, swelling, and pain. By blocking COX-2, meloxicam lowers prostaglandin levels, which leads to:

• Decreased inflammation in joints and tissues
• Reduced pain perception
• A slower progression of inflammatory processes

Because meloxicam is more COX-2 selective than older NSAIDs, it tends to cause fewer stomach-related side effects, although gastrointestinal risk is not eliminated. Oral absorption is rapid, with peak plasma concentrations reached within 4-5 hours. The drug’s half-life is approximately 15-20 hours, supporting once-daily dosing for most patients.

Conditions Treated by Mobic

Mobic is approved by the MHRA for the following adult indications:

• Rheumatoid arthritis - to relieve joint pain, swelling, and stiffness.
• Osteoarthritis - to manage pain and improve joint function.
• Ankylosing spondylitis - to reduce spinal inflammation and related discomfort.

These conditions are chronic inflammatory disorders where inflammation is a key driver of symptoms. Meloxicam’s anti-inflammatory action directly targets the underlying pathway.

Who Should Not Use Mobic?

Absolute Contraindications

• Known hypersensitivity to meloxicam, any other NSAID, or any of the tablet’s inactive ingredients.
• History of asthma, urticaria, or allergic reactions after taking aspirin or other NSAIDs.
• Severe renal impairment (creatinine clearance < 30 mL/min).
• Active gastro-intestinal ulcer or bleeding.
• Pregnancy in the third trimester (risk of premature closure of the fetal ductus arteriosus).

Relative Contraindications

• Mild-to-moderate renal or hepatic impairment - dose adjustment may be needed.
• Elderly patients, especially those with reduced kidney function.
• Concurrent use of other NSAIDs, anticoagulants (e.g., warfarin), or antiplatelet agents (e.g., clopidogrel).
• History of cardiovascular disease (e.g., heart failure, ischemic heart disease).

Special Populations

• Pregnancy & lactation: Use only if the benefit outweighs the risk; avoid in the third trimester.
• Elderly: Start with the lowest effective dose (often 7.5 mg) and monitor kidney function.
• Patients with asthma or nasal polyps: Assess carefully for NSAID-triggered respiratory reactions.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Gastro-intestinal discomfort (indigestion, nausea) - often mitigated by taking the tablet with food.
• Headache - usually mild and transient.
• Dizziness - may affect balance; avoid operating heavy machinery if symptomatic.

Serious Adverse Events

• Peptic ulcer disease or gastrointestinal bleeding - seek immediate medical attention if black stools or vomiting blood occur.
• Renal dysfunction - monitor urine output and serum creatinine; discontinue if renal failure develops.
• Severe skin reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis) - requires urgent care.
• Cardiovascular events (e.g., heart attack, stroke) - elevated risk especially with long-term, high-dose therapy.

Drug Interactions

• Anticoagulants (warfarin, DOACs): Increased bleeding risk; more frequent INR monitoring may be necessary.
• Other NSAIDs or aspirin: Additive gastrointestinal toxicity; concurrent use is generally discouraged.
• ACE inhibitors, ARBs, diuretics: May reduce renal perfusion; monitor kidney function closely.
• Lithium: NSAIDs can raise lithium serum levels; check lithium concentrations regularly.
• Methotrexate: NSAIDs may increase methotrexate levels; dose adjustments may be required.

Food and Lifestyle Interactions

• Take with food or a light snack to lessen stomach irritation.
• Alcohol: Moderate consumption may increase gastrointestinal bleeding risk; limit intake.
• Driving: Meloxicam does not commonly impair cognition, but dizziness or vertigo can affect driving ability-exercise caution if symptoms arise.

If you are taking other prescription medicines, over-the-counter products, or herbal supplements, discuss them with your pharmacist or prescriber before starting Mobic.

How to Take Mobic

• Standard dosing:
• 7.5 mg tablet - typically prescribed for osteoarthritis or for patients needing the lowest effective dose.
• 15 mg tablet - commonly used for rheumatoid arthritis or severe ankylosing spondylitis.
• Frequency: Once daily, preferably in the morning with food.
• Swallow whole: Do not crush or chew the tablet, as this may increase gastrointestinal irritation.
• Missed dose: Take the missed tablet as soon as you remember unless it is near the time of the next scheduled dose. Do not double the dose.
• Overdose: Symptoms may include severe stomach pain, nausea, vomiting, drowsiness, or blurred vision. Seek emergency medical care; activated charcoal may be considered if presentation is early.
• Discontinuation: Do not stop abruptly if you have been on high doses for an extended period; tapering is usually unnecessary for standard doses, but discuss any plan with a prescriber.

Dose Adjustments for Special Populations

• Renal impairment (CrCl 30-50 mL/min): Consider the 7.5 mg dose; monitor serum creatinine regularly.
• Hepatic impairment: Use the lowest effective dose; limit treatment duration.
• Elderly patients: Start with 7.5 mg and assess tolerability before any increase.

Monitoring and Follow-Up

Regular monitoring helps detect adverse effects early:

• Renal function: Serum creatinine and estimated glomerular filtration rate (eGFR) every 3-6 months, more often if comorbidities exist.
• Liver enzymes: ALT, AST, and bilirubin checks at baseline and periodically, especially if hepatic disease is present.
• Complete blood count (CBC): Periodic monitoring for unexplained anemia or thrombocytopenia.
• Blood pressure: NSAIDs can cause fluid retention and elevate blood pressure; monitor if you have hypertension.

If any new symptoms develop-such as unexplained swelling, sudden weight gain, or persistent abdominal pain-contact your healthcare provider promptly.

Storage and Handling

• Store Mobic tablets at room temperature (15-30 °C), away from direct sunlight and moisture.
• Keep the container tightly closed to protect from humidity.
• Do not use tablets past the expiry date printed on the packaging.
• Dispose of unused medication safely, preferably through a pharmacy take-back program, to keep it out of reach of children and pets.

Medication-Specific Glossary

COX-2 (Cyclo-oxygenase-2)

An enzyme that produces prostaglandins involved in inflammation and pain; selectively inhibited by meloxicam.

NSAID (Non-steroidal Anti-inflamatory Drug)

A class of medications that reduce inflammation, pain, and fever by blocking COX enzymes.

Gastro-intestinal ulcer

A sore on the lining of the stomach or duodenum that can cause bleeding; NSAIDs increase ulcer risk.

Half-life

The time required for the plasma concentration of a drug to reduce by 50 %; meloxicam’s half-life is ~15-20 hours.

Renal clearance

The volume of plasma cleared of a drug by the kidneys per unit time; important for dosing adjustments in kidney disease.

Medical Disclaimer

This article provides educational information about Mobic and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.